Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

Depending on the disease specifics, patients with melanoma may undergo pre- or post-surgical therapies. Skin melanoma, one of the most serious forms of skin cancer, poses a significant threat to ...

The Mayo Clinic says melanoma starts in the melanocytes, or the cells that make the pigment (melanin) giving skin its color. Melanoma starts on the skin that usually gets sun exposure, so arms, back, ...

Netherlands data reveal how lentigo maligna is treated in the Netherlands, with notable upstaging and recurrence rates. Read ...